Search Results - "Parghane, Rahul"

Refine Results
  1. 1
  2. 2

    Peptide Receptor Radionuclide Therapy of Neuroendocrine Tumors by Basu, Sandip, Parghane, Rahul V., Kamaldeep, Chakrabarty, Sudipta

    Published in Seminars in nuclear medicine (01-09-2020)
    “…Peptide receptor radionuclide therapy (PRRT), over the years, has evolved as an important modality in the therapeutic armamentarium of advanced, metastatic or…”
    Get full text
    Journal Article
  3. 3

    Toxicity manifestations encountered in peptide receptor radionuclide therapy setting by Parghane, Rahul V., Basu, Sandip

    Published in Journal of neuroendocrinology (12-11-2024)
    “…Peptide receptor radionuclide therapy (PRRT) has demonstrated immense promise as a treatment for patients with neuroendocrine tumors (NET) who have…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Variable Tracer Avidity and Interlesional Heterogeneity on 18F-FDG, 68Ga-DOTATATE, and 68Ga-DOTA-FAPi-04 PET/CT Imaging in a Single Individual Patient With Progressive Metastatic Medullary Thyroid Carcinoma by Edamadaka, Yeshwanth, Parghane, Rahul V, Basu, Sandip

    Published in Clinical nuclear medicine (01-11-2024)
    “…In medullary thyroid carcinoma (MTC), distant metastases have few therapeutic options with low success rates and substantial toxicity in many patients,…”
    Get full text
    Journal Article
  6. 6

    Clinical utility of 177Lu‐DOTATATE PRRT in somatostatin receptor‐positive metastatic medullary carcinoma of thyroid patients with assessment of efficacy, survival analysis, prognostic variables, and toxicity by Parghane, Rahul V., Naik, Chinna, Talole, Sanjay, Desmukh, Anuja, Chaukar, Devendra, Banerjee, Sharmila, Basu, Sandip

    Published in Head & neck (01-03-2020)
    “…Background The primary aim of this study was to evaluate the therapeutic efficacy and outcome of 177Lu‐DOTATATE peptide receptor radionuclide therapy (PRRT) in…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Evaluation of Ectopic Kidney Located at the Deep Subcutaneous Region of the Abdominal Wall: Role of Diuretic Renography with 99m Tc-DTPA by Parghane, Rahul V, Basu, Sandip

    Published in Journal of nuclear medicine technology (20-06-2024)
    “…An ectopic kidney is often found inadvertently during CT, ultrasonography, MRI, or urologic physical examination. Ectopic kidneys usually occur in the pelvis…”
    Get full text
    Journal Article
  9. 9

    Role of Novel Quantitative Imaging Techniques in Hematological Malignancies by Parghane, Rahul V., Basu, Sandip

    Published in PET clinics (01-10-2024)
    “…Hematological malignancies exhibit a widespread distribution, necessitating evaluation of disease activity over the entire body. In clinical practice, visual…”
    Get full text
    Journal Article
  10. 10

    177 Lu-DOTATATE PRRT for Multiple Unusual Metastatic Sites in Neuroendocrine Tumor by Parghane, Rahul V., Basu, Sandip

    Published in Clinical nuclear medicine (01-10-2022)
    “…ABSTRACTThyroid gland and orbit are rare sites of metastases in neuroendocrine tumors. We present an extremely rare case of rectal neuroendocrine tumor with…”
    Get full text
    Journal Article
  11. 11

    Thyroid Incidentaloma on 68Ga-PSMA-11 PET/CT Leading to Detection of Thyroid Metastasis in Metastatic Prostate Carcinoma by Parghane, Rahul V., Basu, Sandip

    Published in Clinical nuclear medicine (01-03-2022)
    “…68Ga-labeled prostate-specific membrane antigen (PSMA)-11 PET/CT has evolved as the noninvasive imaging modality of choice in prostatic adenocarcinoma to…”
    Get full text
    Journal Article
  12. 12
  13. 13

    False-Positive 68 Ga-DOTATATE PET/CT Findings in Hereditary Hypophosphatemia-Osteomalacia Mimicking Culprit Lesions of Tumor-Induced Osteomalacia by Parghane, Rahul V, Basu, Sandip

    Published in Journal of nuclear medicine technology (01-03-2023)
    “…Ga-DOTATATE PET/CT is an important imaging modality for detection of culprit lesions of tumor-induced osteomalacia in clinically symptomatic patients with…”
    Get full text
    Journal Article
  14. 14

    Combined 177Lu‐PSMA‐617 PRLT and abiraterone acetate versus 177Lu‐PSMA‐617 PRLT monotherapy in metastatic castration‐resistant prostate cancer: An observational study comparing the response and durability by Suman, Sonam, Parghane, Rahul V., Joshi, Amit, Prabhash, Kumar, Talole, Sanjay, Basu, Sandip

    Published in The Prostate (01-11-2021)
    “…Objective The aim of present study was to determine and compare the overall response rates, progression‐free survival (PFS), overall survival (OS), and…”
    Get full text
    Journal Article
  15. 15

    177Lu-DOTATATE PRRT for Multiple Unusual Metastatic Sites in Neuroendocrine Tumor by Parghane, Rahul V., Basu, Sandip

    Published in Clinical nuclear medicine (30-03-2022)
    “…Thyroid gland and orbit are rare sites of metastases in neuroendocrine tumors. We present an extremely rare case of rectal neuroendocrine tumor with metastases…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Complimentary Role of [18F]FDG and [18F]NaF-PET/CT in Evaluating Synchronous Thyroid Carcinoma and Parathyroid Adenoma with Brown Tumors by Edamadaka, Yeshwanth, Parghane, Rahul V, Basu, Sandip

    Published in World journal of nuclear medicine (01-09-2024)
    “…We herein present a patient initially suspected of multiple lytic skeletal metastasis of unknown primary on anatomical imaging. Metabolic imaging by…”
    Get full text
    Journal Article
  18. 18

    Unusual Metastatic Sites and Radioiodine Uptake in Patients of Differentiated Thyroid Carcinoma with Atypical Clinical Presentations: Utilization of 131 I-Whole-Body Scintigraphy with Regional SPECT/CT by Edamadaka, Yeshwanth, Parghane, Rahul V, Basu, Sandip

    Published in World journal of nuclear medicine (01-06-2024)
    “…Differentiated thyroid carcinoma (DTC) usually is slow growing and carries a good prognosis. It most commonly tends to spread locally to regional lymph nodes…”
    Get full text
    Journal Article
  19. 19

    Cutaneous, Subcutaneous, and Bilateral Adrenal Gland Metastases in Progressive Prostate Carcinoma: Theranostic Potential of 68 Ga-PSMA-11 PET/CT Imaging and 177 Lu-PSMA-617 Therapy by Parghane, Rahul V, Basu, Sandip

    Published in Clinical nuclear medicine (01-06-2024)
    “…Prostate carcinoma (PC) is the second most common malignant tumor in males globally. The metastatic spread of PC usually involves the pelvic and abdominal…”
    Get full text
    Journal Article
  20. 20

    Combined 177 Lu-PSMA-617 PRLT and abiraterone acetate versus 177 Lu-PSMA-617 PRLT monotherapy in metastatic castration-resistant prostate cancer: An observational study comparing the response and durability by Suman, Sonam, Parghane, Rahul V, Joshi, Amit, Prabhash, Kumar, Talole, Sanjay, Basu, Sandip

    Published in The Prostate (01-11-2021)
    “…The aim of present study was to determine and compare the overall response rates, progression-free survival (PFS), overall survival (OS), and clinical toxicity…”
    Get full text
    Journal Article